Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Massachusetts Institute of Technology · Alnylam Pharmaceuticals (United States) · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,170
total citations
- FWCI
- 33.32
- Percentile
- 100%
- References
- 29
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Small interfering RNA
- Biodistribution
- Nanoparticle
- Nucleic acid
- Biophysics
- In vivo
- Internalization
- Nanotechnology
No related works found for this paper.